New consultancy aims to deliver personalised senior expertise in healthcare communications

Results show disease control and tumour shrinkage with GNS561 and MEK inhibitor combination

Trial shows GRI-0621 improved lung function with signs of fibrosis resolution

MajesTEC-3 study supports teclistamab plus daratumumab SC as potential standard of care

Proof-of-concept phase begins with first patient enrolled

Gene therapy shows sustained benefit for adults with haemophilia B

Novel inhaled ENaC blocker shows promise for treatment of cystic fibrosis

SMC approves targeted therapy for patients with EGFR exon 20 insertion mutations

Johnson & Johnson reports phase 3 data highlighting durable outcomes and immune fitness benefits